Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2013
06/26/2013CN101152310B Traditional Chinese medicine liquid capsule and its preparing method
06/25/2013US8470980 Extracellular targeted drug conjugates
06/25/2013US8470969 Apo-2 ligand/trail formulations
06/25/2013US8470967 Phase transition biopolymers and methods of use
06/25/2013US8470892 Method of inducing neovascularization
06/25/2013US8470891 Biodegradable block polymers for drug delivery, and methods related thereto
06/25/2013US8470347 Mixture of active materials, lipid and binder
06/25/2013US8470332 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
06/25/2013US8470331 Induce immunology response; antiallergens; bioavailability; autoimmune disease, anticancer agents, antiallergens
06/25/2013US8470318 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
06/25/2013US8470315 Non-natural ribonuclease conjugates as cytotoxic agents
06/25/2013US8470301 Particulate materials
06/25/2013US8470294 Flexible and/or elastic brachytherapy seed or strand
06/25/2013US8469034 Stem cell targeting and activation using magnetic particles
06/25/2013DE202010017989U1 Stabilisiertes immunkorrigierendes Heilmittel zur Behandlung von infektiös-entzündlichen Erkrankungen Stabilized immune corrective remedies for the treatment of infectious-inflammatory diseases
06/25/2013CA2692295C Combined use of methylol-transfer agents and fas-ligands in the treatment of cancer
06/25/2013CA2591767C Solid lipidic particles as pharmaceutically acceptable fillers or carriers for inhalation
06/25/2013CA2548106C Therapeutic microparticles
06/25/2013CA2496422C Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor
06/25/2013CA2482464C Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
06/25/2013CA2454920C Antigenic compositions
06/25/2013CA2444894C Sustained release drug delivery system containing codrugs
06/25/2013CA2405378C Stable taurolidine electrolyte solutions
06/20/2013WO2013090893A1 Gastroretentive controlled release vehicles that include ethylene copolymers, ethyl celluloses, and/or thermpoplastic polyurethanes
06/20/2013WO2013090891A1 Controlled release vehicles having desired void volume architectures
06/20/2013WO2013090861A1 Alpha-aminoamidine polymers and uses thereof
06/20/2013WO2013090842A2 Ophthalmic compositions comprising polyvinyl capralactam-polyvinyl acetate-polyethylene glycol graft copolymers
06/20/2013WO2013090804A2 Nanoparticles with enhanced mucosal penetration or decreased inflammation
06/20/2013WO2013090666A1 Compositions containing kinase inhibitors
06/20/2013WO2013090634A1 Use of polymeric excipients for lyophilization or freezing of particles
06/20/2013WO2013090576A1 Painting the pia, arachnoid, and spinal cord parenchyma
06/20/2013WO2013090461A1 Statin bioavailability enhancement delivery composition
06/20/2013WO2013090452A1 Sustained release particle formulations
06/20/2013WO2013090293A1 Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors
06/20/2013WO2013089986A1 Improved denaturants for sympathomimetic amines
06/20/2013WO2013089689A1 Constituent of desmodium elegans and methods of use
06/20/2013WO2013089656A1 Topical pharmaceutical compositions of thiocolchicoside and methylsulfonylmethane
06/20/2013WO2013089522A1 Novel oligonucleotide conjugates and use thereof
06/20/2013WO2013089493A1 Anti-adhesive composition, surgical mesh complex containing same for anti-adhesion functions, and method for manufacturing same
06/20/2013WO2013089489A1 Orally disintegrating tablet, and method for preparing same
06/20/2013WO2013089411A1 Gene nanocomposite, and cellular internalization method of gene using same
06/20/2013WO2013089394A2 Composition of an aqueous solution of polymeric nanoparticles and method for preparing same
06/20/2013WO2013089182A1 Novel branched polyethylene glycol, and use thereof
06/20/2013WO2013089152A1 Lipid nanoparticles containing combinations of cationic lipids
06/20/2013WO2013089151A1 Lipid nanoparticles for drug delivery system containing cationic lipids
06/20/2013WO2013089140A1 Method for producing antimicrobial composition
06/20/2013WO2013088395A1 Clicked somatostatin conjugated analogs for biological applications
06/20/2013WO2013088381A1 Gel compositions
06/20/2013WO2013088380A1 Gel compositions
06/20/2013WO2013088379A1 A topical composition comprising an ingenol derivative and a surfactant-cosolvent mixture
06/20/2013WO2013088376A1 Gel compositions
06/20/2013WO2013088375A1 A topical composition comprising an ingenol derivative and an oily solvent
06/20/2013WO2013088304A1 Combination of inotuzumab ozogamicin and torisel for the treatment of cancer
06/20/2013WO2013088255A1 Prodrugs of secondary amine compounds
06/20/2013WO2013088230A1 Composition for electronic cigarettes
06/20/2013WO2013088216A1 Mixed poloxamer excipients
06/20/2013WO2013088141A1 Polypeptide comprising the sequence egpwleeeeeayg linked to an immunogenic carrier
06/20/2013WO2013087815A1 Liquid pharmaceutical composition containing a pyrazolopyrimidine derivative and pharmaceutical uses thereof
06/20/2013WO2013087808A1 Pharmaceutical composition comprising a pyrazolopyrimidme and cyclodextrin
06/20/2013WO2013087716A2 New antibody drug conjugates (adcs) and the use thereof
06/20/2013WO2013087546A1 Pharmaceutical composition with improved bioavailability for high melting hydrophobic compound
06/20/2013WO2013087234A1 Nanoparticles and uses thereof
06/20/2013WO2013086731A1 Delivery apparatus
06/20/2013WO2013086636A1 Soluble igf receptor fc fusion proteins and uses thereof
06/20/2013US20130158135 Organogel Compositions Comprising Alkylated Aromatic Acids
06/20/2013US20130158134 Use of a safe, green and biodegradable absorptive material in the construction of diapers, feminine hygiene and adult incontinence products and devices
06/20/2013US20130158133 Method of treating carbohydrate rich foods for reducing their glycemic indicies
06/20/2013US20130158132 Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans
06/20/2013US20130158092 New Oral Formulation
06/20/2013US20130158048 Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans
06/20/2013US20130157963 Ophthalmic compositions comprising polyvinyl capralactam-polyvinyl acetate-polyethylene glycol graft copolymers
06/20/2013US20130157939 Compositions for gastric delivery of active agents
06/20/2013US20130157933 Albumin fusion proteins
06/20/2013US20130157931 Mitochondrial penetrating peptides as carriers for antimicrobials
06/20/2013US20130157926 Boronated polymers
06/20/2013US20130157924 Reducing transmission of sexually transmitted infections
06/20/2013US20130156867 Artificial Tear Emulsion
06/20/2013US20130156853 Liquid Compositions of Insoluble Drugs and Preparation Methods Thereof
06/20/2013US20130156835 Novel formulations of active ingredient(s) of plant origin or synthetic analogues thereof or of extract(s) of plant origin containing same, and of lecithin
06/20/2013US20130156831 Thickening Composition And Cosmetic Preparation Containing The Same
06/20/2013US20130156829 Coating agent for pharmaceutical solid preparation, pharmaceutical film formulation, and coated pharmaceutical solid preparation
06/20/2013US20130156828 Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties and Methods of Administering the Same
06/20/2013US20130156817 Surface immobilized chaperones
06/20/2013US20130156796 Method of Treatment of Tumors That Are Resistant to EGFR Therapies by EGFR Antibody Cytotoxic Agent Conjugate
06/20/2013US20130156794 Immunotherapy using redirected allogeneic cells
06/20/2013US20130156782 Monoclonal Antibodies for Treatment of Cancer
06/20/2013US20130156752 Medical organogel processes and compositions
06/20/2013US20130156722 Polymeric drug delivery conjugates and methods of making and using thereof
06/20/2013US20130156721 Cyclodextrin-based polymers for therapeutics delivery
06/20/2013US20130156698 Tissue targeting
06/20/2013US20130156697 Isolated protein medicament
06/20/2013US20130156693 Anti-tat226 antibodies and immunoconjugates
06/20/2013CA2858593A1 Use of polymeric excipients for lyophilization or freezing of particles
06/20/2013CA2858389A1 Soluble igf receptor fc fusion proteins and uses thereof
06/20/2013CA2857337A1 Compositions containing kinase inhibitors
06/20/2013CA2850706A1 Pharmaceutical composition with improved bioavailability for high melting hydrophobic compound
06/20/2013CA2799881A1 Nasal wash solution
06/19/2013EP2604623A2 Transferrin variants and conjugates
06/19/2013EP2604621A1 Method and Carrier Complexes for Delivering Molecules to Cells
06/19/2013EP2604288A1 Nanoparticles and uses thereof
1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 1712